Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Neural Regeneration Research|September 24, 2024
The dopaminergic system and Alzheimer's diseaseYuhan Zhang, Yuan Liang, Yixue GuExpert Review of Neurotherapeutics|April 18, 2014
Epilepsy in women with gynecologic malignanciesYixue Gu, Qin Yang, Xuefeng WangPlos One|December 20, 2012
Microarray-assisted pathway analysis identifies MT1X & NFκB as mediators of TCRP1-associated resistance to cisplatin in oral squamous cell carcinomaBo Peng, Yixue Gu, Yan Xiong, et al.Protein Expression and Purification|February 28, 2012
Purification and biochemical characterization of a novel protein-tongue cancer chemotherapy resistance-associated protein1 (TCRP1)Bo Peng, Sisi Yi, Yixue Gu, et al.Seizure|December 19, 2022
Levetiracetam induces severe psychiatric symptoms in people with epilepsyKaiyan Tao, Hongnian Chen, Yuanyuan Chen, et al.Frontiers in Immunology|March 16, 2019
Application of Plasma Exchange in Steroid-Responsive EncephalopathyYuting Jiang, Xin Tian, Yixue Gu, et al.Oncology Letters|April 30, 2017
TCRP1 expression is associated with platinum sensitivity in human lung and ovarian cancer cellsXiaorong Liu, Meiling Feng, Guopei Zheng, et al.Anti-Cancer Drugs|May 13, 2014
FOXO3a mediates the cytotoxic effects of cisplatin in lung cancer cellsHao Liu, Jiang Yin, Chengkun Wang, et al.Journal of Experimental & Clinical Cancer Research : CR|September 10, 2017
Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cellsXiaomin Feng, Hao Liu, Zhijie Zhang, et al.Molecular and Cellular Biochemistry|September 28, 2014
TCRP1 contributes to cisplatin resistance by preventing Pol β degradation in lung cancer cellsXiaorong Liu, Chengkun Wang, Yixue Gu, et al.Pageof 4